ADHD Market Size To Exceed $24.9 Billion By 2025: Grand View Research, Inc.

Posted on 2019-02-27 by researchinsights in Pharmaceuticals // 0 Comments

San Francisco, United States, 2019-Feb-27 — /EPR Network/ —

The global attention deficit hyperactivity disorder market size is expected to reach USD 24.9 billion by 2025, based on a new report by Grand View Research, Inc., exhibiting a 6.4% CAGR during the forecast period. Increase in awareness regarding ADHD among patients, physicians, and other healthcare providers is likely to up demand for effective treatment, in turn, propelling market growth.

Furthermore, there has been a steady rise in ADHD patients during the last 20 years. According to a study conducted by the National Health Interview Survey, the prevalence of ADHD among children and adolescents in U.S. rose from 6.1% in 1997-1998 to 10.2% in 2015-2016.

Approval and commercialization of drugs, increase in number of clinical trials, and rise in awareness regarding diagnosis and treatment of the condition is expected to boost market growth over the forecast period.

To view summary of this report, click the link below:
www.grandviewresearch.com/industry-analysis/attention-deficit-hyperactivity-disorder-adhd-market

Further key findings from the study suggest:

Increasing access to health insurance for mental health treatment and rising incidence of ADHD are expected to propel market growth in the coming years
By drug type, the stimulant drugs segment accounted for the largest share in the market in 2018 and is anticipated to maintain its dominance during the forecast period. This can be attributed to effectiveness of drugs in treating of ADHD symptoms and commercialization of new drugs
Based on demographics, adults held the maximum share in the ADHD market in 2018 due to high prevalence of the condition across the globe, increased awareness about mental health, and launch of effective drugs with minimum adverse effects
By distribution channel, retail pharmacy accounted for the largest share in 2018 due to increasing number of prescriptions. This can be attributed to rise in patient care initiatives by retail pharmacies
Geographically, North America dominated the global ADHD market in 2018 owing to high awareness of mental health, increasing patient population, and local presence of market players
Asia Pacific is anticipated to observe significant growth during the forecast period owing to government initiatives to provide effective treatment for ADHD and rising patient population due to stressful lifestyle
Some of the key players in the market are Eli Lily & Company; Pfizer; Johnson & Johnson Services, LLC; Lupin; Shire; Mallinckrodt; Prude Pharma L.P.; and NEOS Therapeutics Inc.

Related Report of Pharmaceuticals:

Arthroscopy Market
North America Opioid Market

Grand View Research has segmented the global ADHD market by drug type, demographic, distribution channel, and region:

ADHD Drug Outlook (Market Revenue in USD Million, 2014 – 2025)

Amphetamine
Methylphenidate
Lisdexamfetamine
Dexmethylphenidate
Atomoxetine
Guanfacine
Clonidine
Bupropion

ADHD Drug Type Outlook (Market Revenue in USD Million, 2014 – 2025)

Stimulant
Non-stimulant

ADHD Demographic Outlook (Market Revenue in USD Million, 2014-2025)

Adult (Aged 18 and above)
Children

ADHD Distribution Channel Outlook (Market Revenue in USD Million, 2014-2025)

Retail Pharmacy
Hospital Pharmacy

ADHD Regional Outlook (Market Revenue in USD Million, 2014 – 2025)

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
Asia Pacific
- China
- Japan
Latin America
- Brazil
- Mexico
Middle East and Africa
- South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Matched content

Editor’s pick